This is an early safety study testing a single injection of an experimental gene therapy called RTx-015 into the eye. It aims to see if the treatment is safe for adults with retinitis pigmentosa or choroideremia, two inherited diseases that cause vision loss. Researchers will giv…
Phase: PHASE1 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC